Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Pfizer

Pfizer CEO Albert Bourla sees ‘a scientific renaissance’ in the U.S. amid backdrop of political threats to the future of research

Also: 90% of earnings calls mention tariffs, China says there are no talks with Washington on trade.

Fortune

Novavax says its COVID-19 shot is on track for full FDA approval after delay

Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the Food and Drug Administration

The Independent UK

This Dividend Stock Yields Nearly 8% and Trades at Depressed Valuations: Time to Buy?

Amid the continued decline in Pfizer stock, its dividend yield has risen to almost 8%. While the stock might not be a screaming buy, it now seems to have limited downside.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Eli Lilly Rockets 14% After Solidifying Its Lead For A Weight-Loss Pill

Eli Lilly stock jetted higher Thursday after the company said its diabetes and weight-loss pill helped patients lose up to 16 pounds.

Investors Business Daily

Zimmer Biomet Hits 34th 52-Week Low: Value Play or Value Trap?

Zimmer Biomet hit its 34th 52-week low on Tuesday. Its shares have decreased by over 20% in the past year. Trading at just 11.8x the 2025 EPS estimate, the maker of orthopedic medical devices looks cheap.

Barchart

Pfizer will end development of weight-loss pill over fears about its impact to the liver

The drugmaker said the patient’s injury ‘resolved’ after they stopped taking the drug

The Independent UK

Pfizer stops working on potential pill to treat obesity after study participant has liver injury

Pfizer had intended to move the drug into late-stage testing, but called it quits after a patient in a clinical trial experienced a potentially drug-related liver injury.

Euronews

Read news from The Economist, FT, and more,
with one subscription

Viking Rallies After Pfizer 'Stumble' Highlights The Takeover Candidate — Again

Viking Therapeutics stock rocketed Monday after Pfizer said it's scrapping development of its daily weight-loss pill.

Investors Business Daily

Trump Tariffs Unnerve Locals In Irish 'Pharma' Hub

Vast pharmaceutical factories pepper the green landscape in southern Ireland, but the wind turbines next to the plants outside Cork are in the eye of Donald Trump's global trade storm.

International Business Times

3 Unusally Active Long-Haul Call Options to Buy From Wednesday’s Wild Ride

Yesterday’s S&P 500 move from 4,950 to 5,456.90 at the close was one for the ages. The 90-day pause lit a fire under investors. These three unusually active long-haul call options stood out.

Barchart

Huge Unusual Trading in Pfizer Put Options Signals Investors' Bearish Outlook

Large, unusual trading volume in Pfizer put options is accruing today, signaling a bearish outlook by institutional investors in PFE stock. This undoubtedly relates to the Chinese tariffs, and investors' concerns.

Barchart

Trump Tariff News: New Tariffs Begin, China Retaliates; Treasury Yields Spike While Delta, Walmart Pull Guidance

Trump tariff news: President Trump's latest tariffs took effect Wednesday while China stepped up retaliation. Treasury yields are worrisome. Walmart and Delta Air pulled some guidance, citing tariff uncertainty.

Investors Business Daily

Dow Jones, S&P 500 Pharma Names Recover After Trump Backs Off His Tariffs Plan

Pharma names whipsawed Wednesday after Trump said he would enact "major" tariffs on drug imports and then backed off his tariffs — for now.

Investors Business Daily

‘Half the place would be blown to bits’: the Irish villages under threat from Trump’s tariffs

Cork’s pharmaceutical industry, vital to the local economy, is at risk as US trade policies threaten small towns reliant on the sector

The Guardian - UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Fortune

Trump tariffs could soften one of Europe’s most expensive housing markets—if tech workers face layoffs

Tech and pharma employees in Ireland are at risk from an escalating Trump trade war.

Euronews

Did pharma sector dodge Trump’s tariffs? The EU's not so sure

The fear of a trade war over pharmaceuticals between the EU and the US has been avoided for now, but the European Commission remains on guard, considering further tariff deployments likely.

Fortune

Analysts at Trump ally Howard Lutnick’s former firm call RFK Jr. ‘an anti-vax, conspiracy theorist with inadequate training’

RFK Jr. was reportedly behind the ouster of FDA’s top vaccine official and said last week that around 10,000 employees will be laid off at the Department of Health and Human Services.

MarketBeat

2 Healthcare Stocks to Watch as JPMorgan Boosts Gilead Rating

JPMorgan's upgrade on Gilead sparks bullish sentiment for the healthcare sector—here's why stocks like Pfizer and Hims & Hers are promising opportunities.

Get all your
news in one place.

100’s of premium titles.
One news app.

Euronews

Tariff treatment: Six diagnoses for EU pharma sector amid US trade war

Potential US tariffs on pharmaceuticals could set off a ripple effect that extends far beyond the immediate price hikes, as both the US and Europe heavily rely on each other.

Investors Business Daily

Alnylam Jumps As A New Approval Sets Up Its Next Battle With Pfizer, BridgeBio

Alnylam stock jumped Friday after the drugmaker won a second Food and Drug Administration approval for its drug, Amvuttra.

Evening Standard

Pfizer offloads final shares in Sensodyne maker Haleon

Haleon was formed in 2019 by the merger of the consumer healthcare businesses of British pharmaceutical group GSK and US rival Pfizer.

Reason

Are COVID-19 Vaccines Safe and Effective?

Five years after Donald Trump declared a national COVID-19 emergency, here's what the research says.

The Conversation

Treatment for Parkinson’s disease and restless leg syndrome is linked with risky behaviour – here’s what you need to know

Getting a headache and feeling sick are common side-effects for many medicines. Indulging in risky sexual behaviour or pathological gambling – not so common.

Investors Business Daily

Arvinas Plummets 53% On Mixed Results For Its Pfizer-Tied Breast Cancer Drug

Arvinas stock lost half its value Tuesday after the biotech company reported mixed results from its Pfizer-partnered breast cancer drug.

Investors Business Daily

Why Moderna Stock Has Surged 15% This Week Despite Mixed News

Moderna stock has surged more than 20% this week after regulatory filings showed several executives bought shares on the open market.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Trump Administration

737 stories

HHS

731 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.